SailPoint Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? SailPoint Inc. Common Stock trades at $19 (market cap $11.06B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: SailPoint Inc. Common Stock is far larger — about 6.1× Vir Biotechnology Inc. Common Stock's market cap, and SailPoint Inc. Common Stock is more actively traded (3,269,663 versus 1,782,836). Which is the better fit depends on your goals — on Pluang, investors hold SailPoint Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SAIL | VIR | |
|---|---|---|
Market Cap | $11.06B | $1.80B |
Volume | 3,269,663 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $22.85 | $11.78 |
52-Week Low | $10.49 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.76B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →